Literature DB >> 2491837

Effect of oral immunization with Pseudomonas aeruginosa on the development of specific antibacterial immunity in the lungs.

J Freihorst1, J M Merrick, P L Ogra.   

Abstract

Oral administration of Pseudomonas aeruginosa to rats elicited a systemic and mucosal antibody response in the intestinal and respiratory tracts. The antibody response did not influence the course of the disease when immunized animals were subsequently challenged by the introduction of viable bacteria into the lungs.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2491837      PMCID： PMC313078          DOI： 10.1128/iai.57.1.235-238.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  16 in total

1.  Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues.

Authors:  M R McDermott; J Bienenstock
Journal:  J Immunol       Date:  1979-05       Impact factor: 5.422

2.  Protection against enteric bacterial infection by secretory IgA antibodies.

Authors:  E S Fubara; R Freter
Journal:  J Immunol       Date:  1973-08       Impact factor: 5.422

3.  Organ and isotype distribution of plasma cells producing specific antibody after oral immunization: evidence for a generalized secretory immune system.

Authors:  P Weisz-Carrington; M E Roux; M McWilliams; J M PHILLIPS-Quagliata; M E Lamm
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

4.  A rat model of chronic respiratory infection with Pseudomonas aeruginosa.

Authors:  H A Cash; D E Woods; B McCullough; W G Johanson; J A Bass
Journal:  Am Rev Respir Dis       Date:  1979-03

5.  Epidemiology of Pseudomonas aeruginosa infection in patients treated at a cystic fibrosis centre.

Authors:  N Høiby; K Rosendal
Journal:  Acta Pathol Microbiol Scand B       Date:  1980-06

6.  Intranasal administration of a Pseudomonas lipopolysaccharide vaccine in cystic fibrosis patients.

Authors:  R E Wood; J E Pennington; H Y Reynolds
Journal:  Pediatr Infect Dis       Date:  1983 Sep-Oct

7.  Active immunization with lipopolysaccharide Pseudomonas antigen for chronic Pseudomonas bronchopneumonia in guinea pigs.

Authors:  J E Pennington; W F Hickey; L L Blackwood; M A Arnaut
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

8.  Safety and immunogenicity of high molecular weight polysaccharide vaccine from immunotype 1 Pseudomonas aeruginosa.

Authors:  G B Pier
Journal:  J Clin Invest       Date:  1982-02       Impact factor: 14.808

9.  Prospective, controlled study of a polyvalent pseudomonas vaccine in cystic fibrosis--three year results.

Authors:  D T Langford; J Hiller
Journal:  Arch Dis Child       Date:  1984-12       Impact factor: 3.791

10.  Effect of immunization against rubella on lactation products. I. Development and characterization of specific immunologic reactivity in breast milk.

Authors:  G A Losonsky; J M Fishaut; J Strussenberg; P L Ogra
Journal:  J Infect Dis       Date:  1982-05       Impact factor: 5.226
View more
  8 in total

1.  Informative value of a mouse model of Klebsiella pneumoniae infection used as a host-resistance assay.

Authors:  J Malina; J Hofmann; J Franĕk
Journal:  Folia Microbiol (Praha)       Date:  1991       Impact factor: 2.099

Review 2.  Vaccination strategies for mucosal immune responses.

Authors:  P L Ogra; H Faden; R C Welliver
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

3.  Mucosal immunization with filamentous hemagglutinin protects against Bordetella pertussis respiratory infection.

Authors:  R D Shahin; D F Amsbaugh; M F Leef
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

4.  Intransal or intragastric immunization with proteosome-Shigella lipopolysaccharide vaccines protects against lethal pneumonia in a murine model of Shigella infection.

Authors:  C P Mallett; T L Hale; R W Kaminski; T Larsen; N Orr; D Cohen; G H Lowell
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

5.  Effector mechanisms of intestinally induced immunity to Pseudomonas aeruginosa in the rat lung: role of neutrophils and leukotriene B4.

Authors:  A Buret; M Dunkley; R L Clancy; A W Cripps
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

6.  Pseudomonas aeruginosa exoenzyme S induces proliferation of human T lymphocytes.

Authors:  C H Mody; D E Buser; R M Syme; D E Woods
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

7.  Mucosal and systemic immunizations with killed Pseudomonas aeruginosa protect against acute respiratory infection in rats.

Authors:  A W Cripps; M L Dunkley; R L Clancy
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

Review 8.  Understanding Pseudomonas aeruginosa-Host Interactions: The Ongoing Quest for an Efficacious Vaccine.

Authors:  Maite Sainz-Mejías; Irene Jurado-Martín; Siobhán McClean
Journal:  Cells       Date:  2020-12-05       Impact factor: 6.600
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.